$0.14
▼ $-0.03
(-20.00%)
Vol 38K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$11.5M
ROE
2.7%
D/E
0.00
Beta
-0.03
52W
$5–$154
Wall Street Consensus
8 analysts · Apr 20260
Strong Buy
0
Buy
3
Hold
4
Sell
1
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 66.7%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2025 | $-1.21 | $-0.58 | +$0.63 |
| Jun 2025 | $-1.21 | $-1.20 | +$0.01 |
| Mar 2025 | $-1.21 | $-2.10 | $-0.89 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $183K | $183K | — | — | — |
| Net Income | -$2.1M | -$5.5M | -$3.9M | -$3.0M | -$1.7M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | 2.7% | 2.7% | 2.7% | 2.7% | 2.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 0.15 | 0.11 | 0.15 | 0.15 | 0.15 | 0.07 |
Key Ratios
ROA (TTM)
-375.4%
EPS (TTM)
$-9.38
52W High
$153.90
52W Low
$4.51
$4.51
52-Week Range
$153.90
Financial Health
Free Cash Flow
-$2.3M
Net Debt
-$181K
Cash
$328K
Total Debt
$147K
As of Sep 30, 2025
How does ABP compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ABP valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ABP profitability vs Biotechnology peers
ROE
2.7%
▲
104%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-375.4%
▼
704%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
ABP financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
0.1
▼
98%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.0
▼
103%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
ABP fundamentals radar
ABP
Peer median
Industry
ABP profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio